All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

7

Reset

7 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • HS-10506Phase 32 trials

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Insomnia Disorder

  • YZJ-1139Phase 31 trial

    Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Insomnia Disorder

  • RE03Phase 21 trial

    Reconnect Labs · Posttraumatic Stress Disorder (PTSD), Sleep Disturbances and Insomnia

  • SOM001-APhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

  • SOM001-BPhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

  • SOM001-CPhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

  • SOM001-DPhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.